Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05041465 · ClinicalTrials.gov registry record · NA

The Cosmetic Effect of Mineral Clay Masks

A NA study of Rhytides, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
41
Enrollment target
1
Study location

NCT05041465: Completed NA study of Rhytides, sponsored by University of California, Davis.

NCT05041465 is a NA study of Rhytides that has completed, run by University of California, Davis. The registered enrollment target is 41 participants, above the 15-participant average among 5 other Rhytides trials with a reported enrollment target (173% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05041465, a NA study of Rhytides, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to evaluate the cosmetic effects of commercially available mineral clay masks over a 4-week period. Changes in skin pigmentation, shine, wrinkles, and texture will be assessed. A second aim of the study is to assess the safety and tolerability of mineral clay masks by assessing redness and participant feedback.

Primary Outcome

Computer and photography based facial image analysis

Conditions Studied

Interventions

  • OTHER Clay mask

Study Locations (1)

California

  • University of California Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2019-01-01
Est. Completion 2020-03-01
Phase NA
University of California, Davis

657 total trials

What the finished NCT05041465 record still lists

NCT05041465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, above the 15-participant average among 5 other Rhytides trials with a reported enrollment target (173% higher).

The record links to 1 condition, with Rhytides appearing as the primary indexed condition, and to 1 intervention - of which Clay mask is the first listed.

NCT05041465 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05041465 about?

NCT05041465 is a clinical study titled "The Cosmetic Effect of Mineral Clay Masks". The aim of this study is to evaluate the cosmetic effects of commercially available mineral clay masks over a 4-week period. Changes in skin pigmentation, shine, wrinkles, and texture will be assessed. A second aim of the study is to assess the safety and tolerability of mineral clay masks by asses...

What is the current status of trial NCT05041465?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-01-01. Estimated completion is 2020-03-01.

What conditions does trial NCT05041465 study?

This clinical trial studies the following conditions: Rhytides.

What interventions are being tested in trial NCT05041465?

The interventions under investigation include: Clay mask (OTHER).

Who is sponsoring clinical trial NCT05041465?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05041465 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rhytides

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05041465, the US trial registry maintained by the National Library of Medicine. NCT05041465 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.